From Limitations to Long-Term Survival in HCC: Empowering Patients With Early Diagnosis and Novel Immunotherapy-Based Combination Regimens

Supported by: AstraZeneca
Organized by: Answers in CME
Presenters:
Ghassan Abou-Alfa, MD, MBA
Amit Singal, MD
Andrea Wilson Woods, MPW
Investigations into novel first-line immunotherapy-based combination regimens for unresectable hepatocellular carc

Subscribe to